SSMIP, CHU Bordeaux, Bordeaux, France; MeRISP, Centre Inserm U 1219, Bordeaux Population Health, Université de Bordeaux, France.
SSMIP, CHU Bordeaux, Bordeaux, France; MeRISP, Centre Inserm U 1219, Bordeaux Population Health, Université de Bordeaux, France.
Vaccine. 2022 Jan 21;40(2):178-182. doi: 10.1016/j.vaccine.2021.11.023. Epub 2021 Nov 19.
France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy.
法国是世界上对疫苗最持怀疑态度的国家之一,包括对 2019 年冠状病毒病(COVID-19)的疫苗。在实施了 10 个月的限制措施和媒体对 COVID-19 危险的报道后,法国人对接种疫苗的态度继续恶化。政府的沟通策略没有起到帮助作用;事实上,反而使情况变得更糟。对法国 COVID-19 大流行管理国家战略的实证研究揭示了疫苗犹豫的原因。这些研究确定了疫苗接种策略的四个支柱:i)关于群体免疫重要性的沟通,ii)将医务人员作为疫苗接种运动的重点,iii)动员和保证公民咨询,以及 iv)及时获得免费疫苗。本文讨论了支持这一策略的证据。